XML 61 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (26.9) $ (32.5) $ (47.9) $ (60.0)
Less: Amounts attributable to participating securities 0.0 (9.7) (10.3) (19.2)
Net loss attributable to common stockholders $ (26.9) $ (42.2) $ (58.2) $ (79.2)
Denominator:        
Weighted average shares outstanding- basic (shares) 69,267 48,840 62,060 48,661
Weighted average shares outstanding- diluted (shares) [1] 69,267 48,840 62,060 48,661
Loss per share:        
Basic (in USD per share) $ (0.39) $ (0.86) $ (0.94) $ (1.63)
Diluted (in USD per share) [1] $ (0.39) $ (0.86) $ (0.94) $ (1.63)
Stock options        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 2,016 0 1,901 42
Restricted shares        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 1,484 530 1,451 545
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.